We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Direct Bacterial Identification and Antimicrobial Susceptibility Test Evaluated

By LabMedica International staff writers
Posted on 01 Jul 2021
Print article
Image: The MicroIDSys Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) system (Photo courtesy of ASTA Corp)
Image: The MicroIDSys Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) system (Photo courtesy of ASTA Corp)
Rapid and accurate microbial identification and antimicrobial susceptibility testing (AST) are essential for timely use of appropriate antimicrobial agents for bloodstream infection. Rapid, accurate diagnostic tests, and innovative treatments constitute the key for improvement of bloodstream infection outcome.

The conventional method to detect infectious agents from the positive blood cultures usually takes up to several days due to sub-culturing onto solid agar plates and biochemical tests. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), which can identify the microorganisms from the colonies within minutes, has proven over the years to be a rapid and accurate method for identification of microorganisms.

Medical Laboratory Scientists at The Catholic University of Korea (Seoul, Korea) prospectively evaluated 124 blood cultures flagged as positive for bacterial growth from August to September 2020. When automated blood culture system showed positive signal, an aliquot from positive blood cultures was subjected to Gram staining and then subcultured. After overnight incubation, a pure colony from the agar plate was used for MALDI-TOF MS analysis with MicroIDSys system (ASTA Corp, Suwon, Korea) and AST by VITEK-2 system (bioMérieux, Marcy l'Etoile, France). For cases showing single morphotype by Gram stain, direct bacterial identification was performed using ASTA Corp’s SepsiPrep kit.

The investigators reported that compared to the conventional method using pure colony, correct direct identification rate was 96.5% and 98.5% for 57 gram-positive isolates and 67 gram-negative isolates, respectively. For direct AST, among the 55 gram-positive isolates, the categorical agreement (CA) for staphylococci, streptococci, and enterococci was 96.7%, 98.4%, and 94.1%, respectively. For 66 gram-negative isolates, the CA for Enterobacterales and non-fermentative gram-negative rods was 99.0% and 96.6%, respectively. A total of three isolates showed “invalid identification”; Streptococcus mitis/oralis, Enterococcus faecium, and Klebsiella oxytoca.

The authors concluded that their study demonstrated the effectiveness of the blood culture pellet prepared with SepsiPrep kit for direct AST as well as rapid and accurate identification. The ASTA SepsiPrep kit was very easy to use because the lysis buffer is freeze-dried and contained in one tube and only two washing steps were needed. Combining use of MicroIDSys Elite system and VITEK-2 system with blood culture pellet provided reliable identification and AST results in same day that the blood culture bottles flagged positive. The study was published in the June, 2021 issue of the Journal of Clinical Laboratory Analysis.

Related Links:
The Catholic University of Korea
ASTA Corp
bioMérieux


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
ACTH Assay
ACTH ELISA
New
Community-Acquired Pneumonia Test
RIDA UNITY CAP Bac

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.